Bausch Health. has been granted a patent for an ophthalmic lens featuring a central zone with a defined optical power and a peripheral zone that includes an add-power offset and a smoothly varying optical power profile, characterized by multiple maxima and minima. GlobalData’s report on Bausch Health gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Bausch Health Companies Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Bausch Health, Cancer treatment biomarkers was a key innovation area identified from patents. Bausch Health's grant share as of June 2024 was 55%. Grant share is based on the ratio of number of grants to total number of patents.

Ophthalmic lens with spatially-modulated optical power profile

Source: United States Patent and Trademark Office (USPTO). Credit: Bausch Health Companies Inc

The patent US12019311B2 describes an innovative ophthalmic lens designed to enhance vision through a unique optical power profile. The lens features a central zone with a defined power and a peripheral zone that extends radially outward. This peripheral zone incorporates an add-power offset relative to the central zone, characterized by a smoothly varying optical power profile that includes multiple maxima and minima. The central zone's diameter is specified to be at least 2.0 mm, with options for it to be between 2.0 to 5.0 mm, and it is designed to be no more than 1 mm smaller than the wearer's pupil. The add power offset can range from 0.5 to 5 diopters, and the lens may also include a transition zone that ensures a continuous variation in power from the optical axis to the outer diameter of the peripheral zone.

Further claims detail the structural and functional aspects of the lens, including the possibility of a step in power between the central and peripheral zones, and the uniformity or variation of base power across the peripheral zone. The lens can be designed as a contact lens, potentially made from hydrogel materials, and may be packaged with a buffered saline solution containing a pharmaceutical agent aimed at reducing myopia progression. The lens is also noted for its rotational symmetry, which may enhance its usability. Overall, the claims outline a sophisticated design intended to provide improved visual acuity through a carefully engineered optical profile.

To know more about GlobalData’s detailed insights on Bausch Health, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies